Buy Day today: Good (67) Broad market participation · no major macro event

Haemonetics Corporation (HAE)

Healthcare Medical Devices

86.80 $

+1.5% vs. previous close

Closing price · As of: 3. Aug 2026

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 2,396 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet HAE
Tick rows to compare them in a chart (up to 4)	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Total Assets	1,483	1,317	1,239	1,237	1,275	1,267	1,820	1,860	1,935	2,196	2,451	2,396
Current Assets	568	487	510	521	576	604	694	756	770	769	935	835
Cash	161	115	140	180	169	137	192	259	284	179	307	245
Cash & Short-Term Investments	161	115	140	180	169	137	192	259	284	179	307	245
Receivables	146	157	153	151	185	165	128	159	179	207	203	217
Inventory	211	186	177	161	194	270	323	293	259	317	365	306
Property, Plant & Equipment	322	338	324	332	344	253	277	258	311	367	332	–
Goodwill	334	268	211	211	211	211	466	467	466	565	604	656
Intangible Assets	245	204	178	157	128	133	365	310	276	406	456	448
Total Liabilities	657	597	499	485	607	680	1,088	1,110	1,117	1,236	1,630	1,600
Current Liabilities	189	185	211	385	236	275	253	442	252	300	578	283
Short-Term Debt	22	43	61	194	28	84	25	221	12	10	304	5.0
Accounts Payable	48	40	43	55	63	51	50	58	64	73	67	51
Long-Term Debt	406	365	254	59	322	306	691	559	754	798	921	1,220
Shareholders' Equity	826	720	740	752	668	587	732	749	818	960	821	796
Retained Earnings	420	316	290	267	161	79	158	202	253	360	352	279
Shares Outstanding	52	51	52	54	53	52	51	51	51	51	51	47

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings